Bumetanide Injection Shortage: Current FDA Status
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bumetanide Injection, a cardiovascular medication, is listed as currently in shortage by the FDA, but some manufacturers report availability as of April 2026.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Bumetanide.
Bumetanide Injection Shortage
What's in Shortage
The generic drug name is Bumetanide Injection, with the brand name BUMETANIDE. It is available in injection dosage form and falls under the cardiovascular therapeutic category. The shortage status is current, with the initial posting date of 01/31/2018 and last updated on 04/02/2026.
Which Manufacturers Are Affected
Fresenius Kabi USA, LLC is the manufacturer listed. Their availability status is as follows:
- For Bumetanide, Injection, 0.25 mg/1 mL (NDC 65219-570-04): Available. Related info: Check wholesalers for inventory. Contact info: 888-386-1300.
- For Bumetanide, Injection, 0.25 mg/1 mL (NDC 65219-572-10): Available. Related info: Check wholesalers for inventory. Contact info: 888-386-1300.
Why There's a Shortage
No specific reason for the shortage has been provided in the source data.
What Patients Should Do
If you depend on this medication, consider talking to your pharmacist about current availability or contacting the manufacturer directly for more information. Patients should always consult their healthcare provider before making any changes related to their medication.
Source
This information is attributed to the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,242 characters here).
Similar severity timing
Same severity (low) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.